Stock Groups

Merck says making progress on meeting surge in lab gear demand -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – A Merck KGaA logo is pictured in Darmstadt (Germany), January 28, 2016. REUTERS/Ralph Orlowski/File Photos

FRANKFURT (Reuters). Germany’s Merck KGaA said its order book for COVID-19-related lab gear is still increasing at a faster rate than sales. However, it had a greater handle of the situation.

After releasing the full quarter-end results, Chief Executive Belen Garijo stated that “we are very well trained at present to deal with supply chain pressures… However, we have made tremendous advances, but our order books continue growing faster than sales,”

“We are getting the situation back on track but it’s going to take a little bit of time to get each and every site up to the necessary targets to be able to fulfil 100% of customer demand,” she said, adding that only single-use bioreactor equipment and filters were affected.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]